ARIAD PHARMACEUTICALS, INC., and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of June 17, 2014 3.625% Convertible Senior Notes due 2019Indenture • June 17th, 2014 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
INDENTURE, dated as of June 17, 2014, between ARIAD Pharmaceuticals, Inc., a Delaware corporation, as issuer (hereinafter sometimes called the “Company”, as more fully set forth in Section 1.01), and Wells Fargo Bank, National Association, a national banking association, as trustee (hereinafter sometimes called the “Trustee”, as more fully set forth in Section 1.01).
June 12, 2014Rights Agreement • June 17th, 2014 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between JPMorgan Chase Bank, National Association, London Branch (“JPMorgan”) and ARIAD Pharmaceuticals, Inc. (“Counterparty”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for the Transaction.
June 12, 2014Letter Agreement • June 17th, 2014 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Warrants issued by ARIAD Pharmaceuticals Inc. (“Company”) to JPMorgan Chase Bank, National Association, London Branch (“JPMorgan”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for the Transaction.
ARIAD PHARMACEUTICALS, INC. Purchase AgreementRights Agreement • June 17th, 2014 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
